{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/enfuvirtide.json","peptide":{"slug":"enfuvirtide","name":"Enfuvirtide","url":"https://peptidescanner.com/peptides/enfuvirtide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":49,"entries":[{"objectId":"story:clinicaltrials-gov-nct00001118-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00001118","domain":"Clinical trials","dateInSource":"2021-11-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00001118-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00001118-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00001118-enfuvirtide-v1","contentSha256":"5b3e1c7bc8466ba69d311ff423d9175db318b0bc94f29d35578d3e0ea9656e8b"},{"objectId":"story:clinicaltrials-gov-nct00002228-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00002228","domain":"Clinical trials","dateInSource":"2005-06-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00002228-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00002228-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00002228-enfuvirtide-v1","contentSha256":"863a0f57c293a634915a00f9bfd88b8af8df438762b6aec630aa9a85d995207b"},{"objectId":"story:clinicaltrials-gov-nct00002239-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00002239","domain":"Clinical trials","dateInSource":"2005-11-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00002239-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00002239-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00002239-enfuvirtide-v1","contentSha256":"86d0c8242a8674f6f5ff415c5b4f742112d061eb8869e090340d2201fd9ae374"},{"objectId":"story:clinicaltrials-gov-nct00008528-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00008528","domain":"Clinical trials","dateInSource":"2005-06-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00008528-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00008528-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00008528-enfuvirtide-v1","contentSha256":"d1f904f20084f2fb7d2aab22ecdd6ec3de0d220af639a240d1c6b70b33ab79a6"},{"objectId":"story:clinicaltrials-gov-nct00021554-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00021554","domain":"Clinical trials","dateInSource":"2005-06-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00021554-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00021554-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00021554-enfuvirtide-v1","contentSha256":"5a489a8a02b89e4e482444e3447e518a60dba4fcfe6c327654f15cce5abe5145"},{"objectId":"story:clinicaltrials-gov-nct00022763-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00022763","domain":"Clinical trials","dateInSource":"2016-02-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00022763-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00022763-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00022763-enfuvirtide-v1","contentSha256":"a95a890444af9023c96a320637c47c81b22e5a58318d74a31d2c1ce7dd36b446"},{"objectId":"story:clinicaltrials-gov-nct00031044-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00031044","domain":"Clinical trials","dateInSource":"2021-11-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00031044-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00031044-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00031044-enfuvirtide-v1","contentSha256":"2d865c8250ad2e75cc22c602773d0af32013a5355d0207826ea3c8a4292d24ab"},{"objectId":"story:clinicaltrials-gov-nct00051831-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00051831","domain":"Clinical trials","dateInSource":"2021-11-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00051831-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00051831-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00051831-enfuvirtide-v1","contentSha256":"c816e73b2e9f27f435a7abc9e55b073316aeb2a4400f5c0034fe6b35c5f5c02b"},{"objectId":"story:clinicaltrials-gov-nct00086710-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00086710","domain":"Clinical trials","dateInSource":"2005-06-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00086710-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00086710-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00086710-enfuvirtide-v1","contentSha256":"6b162bd95245c937e8548fd6a309d153f4294060de58ac7d27a6a947eec99ad1"},{"objectId":"story:clinicaltrials-gov-nct00120367-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00120367","domain":"Clinical trials","dateInSource":"2026-04-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00120367-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00120367-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00120367-enfuvirtide-v1","contentSha256":"a4288893a1ce51fd0895bd2a7d31a8543963b878b23a3729eb996d94ffc7fd70"},{"objectId":"story:clinicaltrials-gov-nct00302822-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00302822","domain":"Clinical trials","dateInSource":"2026-04-07","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00302822-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00302822-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00302822-enfuvirtide-v1","contentSha256":"0c8e55bee661d9949febc91926cb7ab0ecba84cbc77919efe7447c59bc2a6aad"},{"objectId":"story:clinicaltrials-gov-nct00334022-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00334022","domain":"Clinical trials","dateInSource":"2012-06-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00334022-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00334022-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00334022-enfuvirtide-v1","contentSha256":"46d00e87f934a3bea1d0ae8a75e0d3ba07161df7928b959fe2d5128ecba3a956"},{"objectId":"story:clinicaltrials-gov-nct00344760-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00344760","domain":"Clinical trials","dateInSource":"2021-05-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00344760-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00344760-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00344760-enfuvirtide-v1","contentSha256":"7e8a7e34ab028e39ebaeb346f454a0b775c444bf18743b5f60c8ecb22bc722e3"},{"objectId":"story:clinicaltrials-gov-nct00460382-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00460382","domain":"Clinical trials","dateInSource":"2010-09-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00460382-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00460382-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00460382-enfuvirtide-v1","contentSha256":"dd74761005d76291f6795cdda3edb416ec420fc745adfeded461f9d2583ae795"},{"objectId":"story:clinicaltrials-gov-nct00487188-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00487188","domain":"Clinical trials","dateInSource":"2015-08-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00487188-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00487188-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00487188-enfuvirtide-v1","contentSha256":"2f04e9cd46b2102ba321407154a1186fc084ae226493cf141700378e4611d676"},{"objectId":"story:clinicaltrials-gov-nct00537394-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00537394","domain":"Clinical trials","dateInSource":"2021-11-04","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00537394-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00537394-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00537394-enfuvirtide-v1","contentSha256":"2f64419a20567eab5b007a440596fe8b79bcbda07d6709c1cca31b06b98b5e13"},{"objectId":"story:clinicaltrials-gov-nct00624195-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00624195","domain":"Clinical trials","dateInSource":"2014-04-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00624195-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00624195-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00624195-enfuvirtide-v1","contentSha256":"a438d211397db1e3d0f1213a578ee7e7a5af58dd967b37b6008fd7fec6f7bc0d"},{"objectId":"story:clinicaltrials-gov-nct00657761-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00657761","domain":"Clinical trials","dateInSource":"2008-04-14","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00657761-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct00657761-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct00657761-enfuvirtide-v1","contentSha256":"2e176fb2d1cb535eba8ba62e78be757df231481c148ac11cde3375c2281533d6"},{"objectId":"story:clinicaltrials-gov-nct01836068-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01836068","domain":"Clinical trials","dateInSource":"2021-11-23","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01836068-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct01836068-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct01836068-enfuvirtide-v1","contentSha256":"370c9020defdcdb119ae25eac0f2084b320b8fec48e1a5f0352905c93c36e2f0"},{"objectId":"story:clinicaltrials-gov-nct02569502-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02569502","domain":"Clinical trials","dateInSource":"2016-11-02","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02569502-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct02569502-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct02569502-enfuvirtide-v1","contentSha256":"64f2f806efc067b999c26ce1b89282afe52b638ff883fa77a6e3f3edca3e6b56"},{"objectId":"story:clinicaltrials-gov-nct02582983-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02582983","domain":"Clinical trials","dateInSource":"2016-07-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02582983-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct02582983-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct02582983-enfuvirtide-v1","contentSha256":"729f30861c336e316a22f92d4bdfa7ac0f6ac95007e56a2f7fce4d5b2bf004bc"},{"objectId":"story:clinicaltrials-gov-nct02733419-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02733419","domain":"Clinical trials","dateInSource":"2016-04-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02733419-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#clinicaltrials-gov-nct02733419-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#clinicaltrials-gov-nct02733419-enfuvirtide-v1","contentSha256":"631a6c1b1e01acd3a43a0eee2837b17a06bc406faefc0ca10c3443b81c494f44"},{"objectId":"story:fda-drugs-nda021481:v1","state":"current","stateChangedAt":"2026-11-16","title":"Drugs@FDA application NDA021481","domain":"Regulatory","dateInSource":"2003-03-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda021481/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#fda-drugs-nda021481-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#fda-drugs-nda021481-v1","contentSha256":"7a66b69b0dea887e8067794887b8457d2308e69562504f0426fcb4368b4aedee"},{"objectId":"story:federal-register-e6-15554:v1","state":"current","stateChangedAt":"2026-11-16","title":"Federal Register notice E6-15554","domain":"Regulatory","dateInSource":"2006-09-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/federal-register-e6-15554/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#federal-register-e6-15554-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#federal-register-e6-15554-v1","contentSha256":"d3ca94cfc44ff47fa03c8431e884806d4028db48cf767274895a659a5b2581d5"},{"objectId":"story:pubmed-pmid-12457443-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide.","domain":"Literature metadata","dateInSource":"2019-09-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12457443-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-12457443-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-12457443-enfuvirtide-v1","contentSha256":"a4260d2f3b38530c2aceda7ac01ceadf69fb01b6199949707eb11cd9b1e42116"},{"objectId":"story:pubmed-pmid-12562683-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.","domain":"Literature metadata","dateInSource":"2019-05-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12562683-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-12562683-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-12562683-enfuvirtide-v1","contentSha256":"833ba7d0ad7758c3e85d28c017dfd27a6cb31d5bc4246f2b28a043321e70050a"},{"objectId":"story:pubmed-pmid-14664654-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide.","domain":"Literature metadata","dateInSource":"2026-10-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-14664654-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-14664654-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-14664654-enfuvirtide-v1","contentSha256":"e58d4b9d89c825b16da80dd1b26f4a44fc6783027b4eec127ae43fd68dcfe317"},{"objectId":"story:pubmed-pmid-15002081-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide: antiretroviral class 4, drug 1.","domain":"Literature metadata","dateInSource":"2018-11-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15002081-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15002081-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15002081-enfuvirtide-v1","contentSha256":"1089ecac0dcc023e7569c548ba7addcf7d7e65901914f738812fa1a3fef8e4b4"},{"objectId":"story:pubmed-pmid-15148534-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide.","domain":"Literature metadata","dateInSource":"2019-11-08","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15148534-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15148534-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15148534-enfuvirtide-v1","contentSha256":"74575232f2cc870ed03edb584799823e3374d11465e58a74569874e3bd466ba7"},{"objectId":"story:pubmed-pmid-15199084-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.","domain":"Literature metadata","dateInSource":"2018-11-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15199084-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15199084-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15199084-enfuvirtide-v1","contentSha256":"33b6e124cd3fe64bc17aedfbf3306e3ead1703bf1463cb23bd7585a301d56a4a"},{"objectId":"story:pubmed-pmid-15258964-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure.","domain":"Literature metadata","dateInSource":"2018-11-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15258964-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15258964-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15258964-enfuvirtide-v1","contentSha256":"3799064633559be686796fa164ac782f824969375aec0772ff60dcd1d46d10fb"},{"objectId":"story:pubmed-pmid-15280778-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Immunological and virological study of enfuvirtide-treated HIV-positive patients.","domain":"Literature metadata","dateInSource":"2019-07-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15280778-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15280778-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15280778-enfuvirtide-v1","contentSha256":"f2486fac67a4221040218eef4dc41caf2fce7ae60ba231c5329dae12c2feca0d"},{"objectId":"story:pubmed-pmid-15316339-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.","domain":"Literature metadata","dateInSource":"2019-07-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15316339-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15316339-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15316339-enfuvirtide-v1","contentSha256":"259c241ee519f663ab2cf80392cc28672f0892be658ee5616500b11ea5f64f20"},{"objectId":"story:pubmed-pmid-15538017-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide (T-20): potentials and challenges.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15538017-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15538017-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15538017-enfuvirtide-v1","contentSha256":"12e175cf9a29dc3e0f6da095ca426b0eff4074d71bd0fa07ce4b0656fdc5ff92"},{"objectId":"story:pubmed-pmid-15626952-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Pharmacokinetics of enfuvirtide in pediatric human immunodeficiency virus 1-infected patients receiving combination therapy.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15626952-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15626952-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15626952-enfuvirtide-v1","contentSha256":"5f446214788722ddd3b26f53606ba5cffacf699472009f25deaafbe5babaa948"},{"objectId":"story:pubmed-pmid-15742551-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Therapeutic indications, antiretroviral treatment optimization and quality of life of patients taking enfuvirtide].","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15742551-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-15742551-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-15742551-enfuvirtide-v1","contentSha256":"b7b856e5d7bc5c4a042e84d33ebb7421514ab0008d96e24a26cad0f3ad7110ee"},{"objectId":"story:pubmed-pmid-16433570-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Enfuvirtide: first drug of a new family of antiretroviral agents].","domain":"Literature metadata","dateInSource":"2019-11-09","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16433570-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-16433570-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-16433570-enfuvirtide-v1","contentSha256":"1f3308c7ce8a904be2bb945e223195d9db5c3e8ebd05a35c24c4dc281e7624b5"},{"objectId":"story:pubmed-pmid-16706613-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2.","domain":"Literature metadata","dateInSource":"2006-11-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16706613-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-16706613-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-16706613-enfuvirtide-v1","contentSha256":"14da540843e8d3aee6f67bbfabf7f4de23a6ce4dbc6656fce7e2a7f121d18b6b"},{"objectId":"story:pubmed-pmid-16759047-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16759047-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-16759047-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-16759047-enfuvirtide-v1","contentSha256":"3161b0ff7c2e3e7689683e1b1395f52f0fcec0e79ff30ebfbb45c7aa4c4d8c51"},{"objectId":"story:pubmed-pmid-17205468-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide antiviral activity despite rebound viremia and resistance mutations: fitness tampering or a case of persistent braking on entering?","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17205468-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-17205468-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-17205468-enfuvirtide-v1","contentSha256":"bb98f18562cefd9b476518a8c2c5ee84b2dc8a9712425591e8aa1caf443aa4cc"},{"objectId":"story:pubmed-pmid-17225316-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Anti-HIV agents. T-20 (enfurvirtide, Fuzeon).","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17225316-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-17225316-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-17225316-enfuvirtide-v1","contentSha256":"a45279d82ee7120481ba146cec82d27479883c0485bf1533b5bdf7680484f40d"},{"objectId":"story:pubmed-pmid-17288910-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"[Spanish recommendations for proper use of enfuvirtide].","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17288910-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-17288910-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-17288910-enfuvirtide-v1","contentSha256":"3424f1390b60bbf1f18c541fd14de5cdd6cab364f789faf6cc06efc4d2c002ac"},{"objectId":"story:pubmed-pmid-17389560-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.","domain":"Literature metadata","dateInSource":"2021-12-03","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17389560-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-17389560-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-17389560-enfuvirtide-v1","contentSha256":"a38a76c07afb2bf82d94c0d756e88f7090d684ed525bb43c3f7d1c19a86a5307"},{"objectId":"story:pubmed-pmid-18710359-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Reassessment of enfuvirtide's role in the management of HIV-1 infection.","domain":"Literature metadata","dateInSource":"2019-09-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18710359-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-18710359-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-18710359-enfuvirtide-v1","contentSha256":"2dc92149a3151d76d30cc37e2922ad6ccf93444d40e98c8f2a627ea9ffe232f2"},{"objectId":"story:pubmed-pmid-19461505-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.","domain":"Literature metadata","dateInSource":"2026-05-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19461505-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-19461505-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-19461505-enfuvirtide-v1","contentSha256":"6e6d2495db43e7cb60f17d78419903f980dff442c0ce6f690f93e6cfcdd75f07"},{"objectId":"story:pubmed-pmid-20001856-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.","domain":"Literature metadata","dateInSource":"2025-05-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20001856-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-20001856-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-20001856-enfuvirtide-v1","contentSha256":"452f4b9daa51ea702be1dada42f428a02a1b7a87f4bf77b71fe3a66a2da549f1"},{"objectId":"story:pubmed-pmid-20977403-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide: from basic investigations to current clinical use.","domain":"Literature metadata","dateInSource":"2018-12-01","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20977403-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-20977403-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-20977403-enfuvirtide-v1","contentSha256":"c908e4eec52f4c9b49a5c61e0e8dd2fb0003368dc09d76dc7370844a24a439e3"},{"objectId":"story:pubmed-pmid-35646620-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Enfuvirtide biosynthesis in thermostable chaperone-based fusion.","domain":"Literature metadata","dateInSource":"2022-07-16","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35646620-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-35646620-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-35646620-enfuvirtide-v1","contentSha256":"a136255e998df39e9f944319d2b9235504f416a008e2e3784c8d527adf9b765c"},{"objectId":"story:pubmed-pmid-37120679-enfuvirtide:v1","state":"current","stateChangedAt":"2026-11-16","title":"Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel.","domain":"Literature metadata","dateInSource":"2023-07-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37120679-enfuvirtide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.json#pubmed-pmid-37120679-enfuvirtide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/enfuvirtide.md#pubmed-pmid-37120679-enfuvirtide-v1","contentSha256":"8a7cf60ac02c8d99e85cd45f96db346ec75e4a7e96e8e972be9412473a298c2f"}]}
